
Recent developments with Aclaris Therapeutics Inc (ACRS) have led to the company’s beta value being reach 0.28 cents.
Aclaris Therapeutics Inc (NASDAQ: ACRS) on Friday, soared 3.82% from the previous trading day, before settling in for the closing price of $1.57. Within the